Manufacturer
GlaxoSmithKline Biologicals, Branch of SmithKline Beecham Pharma GmbH & Co. KG
Contents
Inactivated quadrivalent influenza vaccine (split virion)
Indication
Active immunisation of adults & childn from 6 mth for prevention of influenza disease caused by influenza virus types A & B.
Instruction
Single 0.5 mL IM inj. Childn 6 mth to <9 yr not previously vaccinated against influenza 2nd dose to be given after at least 4 wk interval.
Drug interaction
Fluarix Tetra can be concomitantly administered with pneumococcal vaccines (see Pharmacology: Pharmacodynamics under Actions).
If Fluarix Tetra is to be given at the same time as another injectable vaccine, the vaccines should always be administered at different injection sites.
False positive ELISA serologic tests for HIV-1, Hepatitis C, and especially HTLV-1 may occur following influenza vaccination. These transient false-positive results may be due to cross-reactive IgM elicited by the vaccine. For this reason, a definitive diagnosis of HIV-1, Hepatitis C, or HTLV-1 infection requires a positive result from a virus-specific confirmatory test (e.g., Western Blot or immunoblot).